Search Results - pierre+candelaria

1 Results

Sort By:

2021-043 NOVEL IGE ANTIBODIES FOR THE THERAPY OF CANCER

Researchers at UCLA’s David Geffen School of Medicine have designed three novel antibodies of the IgE class targeting antigens CD138, CD38, and transferrin receptor 1 (TfR1/CD71): cancer antigens present in various hematopoietic and/or solid tumors. There are several advantages of IgE class antibodies compared to the commonly used IgG class in...

Published: 2/15/2024 | Inventor(s): Manuel Penichet, Pierre Candelaria, Miguel Nava, Tracy Wells

Keywords(s): Cancer, Immunoglobulin G

Category(s): Platforms > Drug Delivery > Peptide Base, Therapeutics > Hematology